Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Dec;71(12):9531-7.
doi: 10.1128/JVI.71.12.9531-9537.1997.

Activation of the T-cell receptor signaling pathway by Nef from an aggressive strain of simian immunodeficiency virus

Affiliations

Activation of the T-cell receptor signaling pathway by Nef from an aggressive strain of simian immunodeficiency virus

W Luo et al. J Virol. 1997 Dec.

Abstract

The Nef from a highly virulent strain of simian immunodeficiency virus (SIV), SIVpbj14, and a Nef from the traditional strain SIVmac239 bearing the mutation from RQ to YE (YE-Nef) both induce an acute lethal disease in monkeys. The YE mutation and its surrounding sequence resemble the immunoreceptor tyrosine-based activation motif (ITAM), which is present in the cytoplasmic tail of T- and B-cell antigen receptors and mediates signaling during lymphocyte activation. We show here that the ITAM from YE-Nef performs the same function. First, not only does YE-Nef increase the activity of the transcription factor NFAT, which is one of the downstream targets of T-cell activation, but the ITAM from the YE-Nef by itself also activates NFAT. Second, the ITAM from YE-Nef is phosphorylated on tyrosine residues by Lck and associates with ZAP-70, a T-cell-specific tyrosine kinase. The phosphorylation of both conserved tyrosine residues on the ITAM is required for the recruitment of ZAP-70. Finally, Lck is required for the activation of NFAT by YE-Nef. These results demonstrate that YE-Nef contains a functional ITAM and elucidate the molecular mechanisms underlying the pathogenesis of SIVpbj14.

PubMed Disclaimer

References

    1. FEBS Lett. 1996 Oct 21;395(2-3):257-61 - PubMed
    1. J Gen Virol. 1996 Oct;77 ( Pt 10):2379-92 - PubMed
    1. J Virol. 1996 Dec;70(12):9051-4 - PubMed
    1. Eur J Immunol. 1997 Feb;27(2):554-62 - PubMed
    1. Curr Opin Cell Biol. 1997 Apr;9(2):205-12 - PubMed

Publication types

Substances